1 in 4 California adolescent girls has had HPV vaccine
... The HPV virus is associated with about 90 percent of genital warts and up to 70 percent of all cervical cancers. The vaccine is administered ... and targets the four HPV types most commonly associated with genital warts and cervical cancer. Among those surveyed who had not yet had the ...Fears of promiscuity pose barrier to cervical cancer vaccinations
... promoting the vaccination of girls against HPV to prevent against genital warts and cervical cancer, but the Yale study showed the public believes that ... of those surveyed believed the risk of cervical cancer and genital warts (which are largely spread through sexual contact) is far lower with the ...Study: Benefit to women not enough to sway men to get HPV vaccine
... this finding in a number of ways," Gerend said. "Thinking about the benefit to their own health -- protection again rare genital cancers and genital warts -- is all men really need to know; telling them all that extra stuff really isn't going to push them one way or another." For maximum benefit to ...Cervical Cancer Vaccine Not Just for Teens
... partners around middle age. Their study included more than 3,200 women, aged 24 to 45, with no history of cervical disease or cancer or genital warts caused by HPV types 6, 11, 16 and 18. The women received either the quadrivalent HPV vaccine, which protects against the four HPV types, or a placebo ...Valuable New Resources for Treating Sexually Transmitted Disease (STD)
... disease (STD) and sexually transmitted infection (STI) sections. Common STDs include chlamydia , genital herpes, gonorrhea, syphilis, and genital warts (HPV). These urologychannel enhancements follow a recent announcement made by the Centers for Disease Control and Prevention (CDC) stating that ...PhRMA Honors Gardasil(r) Researchers With Discoverers Award
... in 2008. Footnote Gardasil is approved for the prevention of cervical, vulvar and vaginal cancers caused by HPV types 16 and 18; genital warts caused by HPV types 6 and 11; and precancerous or dysplastic lesions caused by HPV types 6, 11, 16 and 18 in girls and young women nine through 26 ...Circumcision Guards Against STDs
... causes herpes went down by 28 percent, and the transmission of human papillomavirus (HPV) -- the virus that can cause cervical cancer and genital warts -- was reduced by 35 percent. In a previous study, the same researchers found that circumcision reduced infection with the HIV virus by 60 ....Both Latino and non-Latino women likely to accept HPV vaccination for selves and children
... sexually transmitted infection, and vaccination is primarily designed to prevent cervical cancer in women. HPV infection also can cause genital warts and other genital tumors, including cancer of the penis or anus in males. Worldwide, cervical cancer is the second most common cancer in women and ...Gardasil Demonstrates Up to 100% Efficacy
... (VaIN 1-3 and VIN 1-3), and genital warts caused by Human Papillomavirus types 6, 11, 16 ... efficacious against cervical lesions and genital warts after five years of follow up post-enrolment. ,a) ... vulvar lesions) and external genital warts (condyloma acuminata) caused by ...New England Journal of Medicine Publishes New Data on Gardasil, Merck's Cervical Cancer Vaccine
... (VaIN) 2/3), and for the prevention of genital warts and low-grade cervical lesions (CIN 1) caused by ... (VIN 1-3 and VaIN 1-3) and external genital warts caused by the four HPV types targeted by ... the rate of vaginal or vulvar lesions and genital warts caused by vaccine or other HPV types by 34 ...NIH funds $9.5 million for research on HIV and the human innate immune system
... tract and is now being seen in the mouth. warts produced by HPV can lead to cancer and increased ... individuals on HAART, compare tissue samples from warts associated with HIV-positive (on HAART) and ... individuals on HAART, examine tissue samples from warts associated with HIV, and find genetic differences ...Iowa State researchers develop technology for early detection of viruses
... In June of 2006, the U.S. Food and Drug Administration approved a vaccine developed to prevent cervical cancer, precancerous lesions and genital warts caused by four types of the virus. The vaccine has been approved for females ages 9 to 26. The Centers for Disease Control and Prevention reports ...Warts vaccine -- 1 of many in pipeline
... the papillomaviruses responsible for genital warts was on target at the halfway mark, according to ... vaccines to prevent infections. Genital warts are transmitted by skin contact and the 2003 ... Dr Jardine said men and women with genital warts who would like to take part in the trial could ...Synthetic peptide targets latent papilloma virus infections
... already infected and at constant risk of genital warts and cancer. One study found that 75 percent of ... known genetic variants or strains of HPV cause warts in surface tissues, including the penis, vagina ... into nipple-like warts. Unlike unsightly warts on the skin, tongue or ...Teens unaware of sexually transmitted diseases until they catch one, Carnegie Mellon study finds
... in risky sexual behavior and to delay the treatment of STDs. And the consequences are severe. Genital herpes, for example, cannot be cured. Genital warts can render a woman more susceptible to cervical cancer, and chlamydia can lead to infertility. A 2004 study, involving the same group of ...Bradley Pharmaceuticals Launches Veregen(TM) (sinecatechins) Ointment, 15%
... treatment of external genital (EGW) and perianal warts (Condylomata acuminata) in immunocompetent ... new prescription treatment for external genital warts in ten years. Bradley licensed the product from ... side effects reported. External genital warts are one of the most common and fastest ...Helix BioPharma Announces Q3 2009 Financial Results and Provides Product Development Update
... Phase III Clinical Trial Application has not yet been established. Topical Interferon Alpha-2b Product Development Update - Ano-Genital warts Indication ("AGW") Helix is continuing to progress with its ongoing Phase II trial of Topical Interferon Alpha-2b in patients with ano-genital ...Nventa Provides Corporate Update and Advancement Plans for HspE7, Hsp 6/11 and Poly-ICR
... -- Internal Application of Poly-ICR -- Nventa is pursuing the development of Poly-ICR for topical application for the treatment of genital warts (GW) and actinic keratosis, a premalignant condition of the skin. Next development activities include completing toxicology and formulation ...Gen-Probe Launches in Europe CE-Marked APTIMA(R) HPV Assay for Detection of Human Papillomavirus
... resolve without any clinical symptoms or consequences. However, a small number of HPV infections progress and result in disease ranging from genital warts to cervical cancer. Since most HPV infections do not result in cancer, there is a need for a more specific test to identify women at greater risk of ...Nventa Biopharmaceuticals Reports Full Year 2007 and Fourth Quarter Financial Results
... HPV fusions to treat patients with HPV- related diseases -- Granted a U.S. patent covering heat shock protein fusions to treat anogenital warts -- Won an important challenge to two U.S. patents; U.S. Patent and Trademark Office reissued composition of matter and methods of use for ...Helix BioPharma reports Q2 2008 highlights, financial results
... of furnishing product for the clinical trial. Research and development expenditures related to the Phase II trial in Sweden for ano-genital warts ("AGW") were more than offset by the reduction in costs associated with the Phase II study in Germany for women with precancerous, HPV induced ...